Hygea Medical Technology Co., Ltd., founded in 2010, is headquartered in Haidian District, Beijing, China. As a National High-tech Enterprise integrating R&D, production, sales and marketing, the company focuses on Interventional Oncology fields of "percutaneous intervention" and "transvascular intervention".
The first released product, "Co-Ablation System", is leading the industry with the cutting-edge technology, the product introduces the first combined ablation system in the world by integrating cryoablation and hyperthermia ablation in one system. In 2020, Co-Ablation System obtained the CE Marking Certificate and started product marketing in European countries. The Co-Ablation System AI Epic series has won the iF DESIGN AWARD 2020.
The company has set up Beijing Key Laboratory of Cryogenic Biomedical Engineering and Post-Doctoral Research Center. As to patents, the company obtains more than 150 patents both in China and abroad. Hygea Medical Technology Co., Ltd. was granted awards of the William Begell Medal, National Specialized and New "Little Giant" Enterprise, First Prize of Beijing Science and Technology Award, etc.
We are committed to creating a minimally invasive treatment platform-type enterprise.
Chinese and international patents
Number of cumulative Top hospitals installed
Number of cumulative patients treated
「BEST」ABLATION &「FIRST」SHOW | Hygea Medical shows up at「MEDICA」
Deep strategic cooperation between Hygea and CR PHARM COMM
There is such a company. The founder of the company, Huang Qianfu, and his team have spent more than ten years grinding "a probe"-Co-Ablation System, a cryosurgery system for minimally invasive tumor treatment.